Guardant Health (GH) Convertible Debt (2020 - 2026)

Guardant Health has disclosed Convertible Debt across 7 years of filings, most recently posting $1.5 billion for Q1 2026.

• Convertible Debt for Q1 2026 came in at $1.5 billion, up 34.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 34.68% YoY), and the FY2025 annual result was $1.5 billion, up 31.64% from the prior year.
• Convertible Debt came in at $1.5 billion for Q1 2026 at Guardant Health, roughly flat from $1.5 billion in the prior quarter.
• In the past five years, Convertible Debt ranged from a high of $1.5 billion in Q4 2025 to a low of $1.1 billion in Q3 2025.
• The 5-year median for Convertible Debt is $1.1 billion (2023), against an average of $1.2 billion.
• Across the five-year window, Convertible Debt fell 2.39% in 2025 and jumped 34.68% in 2026, its largest moves.
• Guardant Health's Convertible Debt stood at $1.1 billion in 2022, then advanced by 0.23% to $1.1 billion in 2023, then advanced by 0.23% to $1.1 billion in 2024, then jumped by 31.64% to $1.5 billion in 2025, then dropped by 0.04% to $1.5 billion in 2026.
• The last three Convertible Debt figures came in at $1.5 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.